36 related articles for article (PubMed ID: 32126219)
1. Identification of Compounds for Butyrylcholinesterase Inhibition.
Li S; Li AJ; Travers J; Xu T; Sakamuru S; Klumpp-Thomas C; Huang R; Xia M
SLAS Discov; 2021 Dec; 26(10):1355-1364. PubMed ID: 34269114
[TBL] [Abstract][Full Text] [Related]
2. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease.
Saud A; Krishnaraju V; Taha A; Kalpana K; Malarkodi V; Durgaramani S; Vinoth Prabhu V; Saleh FA; Ezhilarasan S
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2522-2537. PubMed ID: 38567612
[TBL] [Abstract][Full Text] [Related]
3. Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer's Disease Activity.
Egbujor MC
Cent Nerv Syst Agents Med Chem; 2024; 24(1):82-104. PubMed ID: 38275073
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives.
Schepetkin IA; Nurmaganbetov ZS; Fazylov SD; Nurkenov OA; Khlebnikov AI; Seilkhanov TM; Kishkentaeva AS; Shults EE; Quinn MT
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110594
[TBL] [Abstract][Full Text] [Related]
5. Effects of hydroalcoholic, methanolic, and hexane extracts of brown algae
Hassanzadeh A; Yegdaneh A; Rabbani M
Res Pharm Sci; 2023; 18(3):292-302. PubMed ID: 37593166
[TBL] [Abstract][Full Text] [Related]
6. In-Vitro, In-Vivo, Molecular Docking and ADMET Studies of 2-Substituted 3,7-Dihydroxy-4H-chromen-4-one for Oxidative Stress, Inflammation and Alzheimer's Disease.
Mahnashi MH; Alshahrani MA; Nahari MH; Hassan SSU; Jan MS; Ayaz M; Ullah F; Alshehri OM; Alshehri MA; Rashid U; Sadiq A
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36355138
[TBL] [Abstract][Full Text] [Related]
7. Isolation, In Vitro and In Silico Anti-Alzheimer and Anti-Inflammatory Studies on Phytosteroids from Aerial Parts of
Mahnashi MH; Alshehri OM
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291639
[TBL] [Abstract][Full Text] [Related]
8. Succinimide Derivatives as Antioxidant Anticholinesterases, Anti-
Alshehri OM; Mahnashi MH; Sadiq A; Zafar R; Jan MS; Ullah F; Alshehri MA; Alshamrani S; Hassan EE
Evid Based Complement Alternat Med; 2022; 2022():6726438. PubMed ID: 35942378
[TBL] [Abstract][Full Text] [Related]
9. 3-(((1
Sadiq A; Mahnashi MH; Rashid U; Jan MS; Alshahrani MA; Huneif MA
Molecules; 2022 May; 27(10):. PubMed ID: 35630740
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective potentials of selected natural edible oils using enzyme inhibitory, kinetic and simulation approaches.
Mahnashi MH; Alyami BA; Alqahtani YS; Alqarni AO; Jan MS; Ayaz M; Ullah F; Shahid M; Rashid U; Sadiq A
BMC Complement Med Ther; 2021 Oct; 21(1):248. PubMed ID: 34600509
[TBL] [Abstract][Full Text] [Related]
11. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
[TBL] [Abstract][Full Text] [Related]
12. Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives.
Ahmad A; Ullah F; Sadiq A; Ayaz M; Saeed Jan M; Shahid M; Wadood A; Mahmood F; Rashid U; Ullah R; Sahibzada MUK; Alqahtani AS; Mahmood HM
Drug Des Devel Ther; 2020; 14():2165-2178. PubMed ID: 32606589
[TBL] [Abstract][Full Text] [Related]
13. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
[TBL] [Abstract][Full Text] [Related]
14. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
[TBL] [Abstract][Full Text] [Related]
15. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
17. Anticholinesterase Agents For Alzheimer's Disease Treatment: An Updated Overview.
Llanes LC; Kuehlewein I; França IV; da Silva LV; da Cruz Junior JW
Curr Med Chem; 2023; 30(6):701-724. PubMed ID: 35927804
[TBL] [Abstract][Full Text] [Related]
18. SAR based in-vitro anticholinesterase and molecular docking studies of nitrogenous progesterone derivatives.
Amin MJ; Miana GA; Rashid U; Rahman KM; Khan HU; Sadiq A
Steroids; 2020 Jun; 158():108599. PubMed ID: 32126219
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
